Skip to main content
Tech.euFundingExplorerBeta

CoV Biotechnology

Exited

CoV Biotechnology is an early-stage Singapore-based biotechnology company focusing on inducing broad, pan-sarbecovirus immune responses to address the evolving and mutating nature of the coronavirus.

CoV Biotechnology is tracked in the Tech.eu funding database. Based in Singapore, Singapore; active in Healthtech. Acquired by Leyden Labs in 2025. Data as of 28 Oct 2026.

Singapore, Singaporewww.covbiotech.com ↗
Healthtech
← All companies
Total raised
—
no tracked rounds
Funding rounds
0
Investors
0
distinct backers
Active since
—

Funding rounds

0 rounds
No funding rounds recorded.

Exit

Type
acquisition
Date
Jan 2025
Value
—
Acquiror
Leyden Labs (Netherlands)

Related news

Similar companies

same sector or country

Global coverage: FundingData